Medical cannabis has shown promise as a potential treatment option for individuals with autism spectrum disorder (ASD). ASD is a neurodevelopmental disorder characterized by challenges in social interaction, communication difficulties, and repetitive behaviors. The underlying pathophysiology of autism involves abnormal brain development and altered neurotransmitter function.
Recent medical journal articles have explored the potential benefits of medical marijuana in managing symptoms associated with autism. For example, a study published in 2021 [1] found that CBD, a non-psychoactive component of cannabis, reduced anxiety and improved behavior in children with ASD.
Another study from 2020 [2] reported that medical cannabis treatment was associated with a reduction in irritability and aggression among individuals with autism. Additionally, medical cannabis has been studied for its potential to improve sleep disturbances and self-injurious behaviors in individuals with ASD [3].
While more research is needed, these studies contribute to the growing body of evidence supporting the potential therapeutic effects of medical cannabis in autism. If you or someone you know is interested in medical marijuana certification, consult a physician first.
1. Study: “Cannabidiol reduces anxiety and behavioral problems in children with autism spectrum disorder.” (2021)
2. Study: “Medical cannabis for pediatric patients with autism spectrum disorder: an observational study.” (2020)
3. Study: “Medical cannabis for the treatment of autism spectrum disorder: a systematic review.” (2020)